Search

everythinglearnresearchcommunity

for

Search:↓

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Breast cancer patients undergoing chemotherapy often worry, lose weight, and cope by praying, meditating, or seeking support.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

A new method quickly extracts and identifies proteins from hair and other keratin sources.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Erlotinib can cause hair loss and texture changes.